10-73912301-G-A

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_002658.6(PLAU):​c.172G>A​(p.Gly58Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0064 in 1,613,398 control chromosomes in the GnomAD database, including 52 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0049 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0066 ( 47 hom. )

Consequence

PLAU
NM_002658.6 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:1B:4

Conservation

PhyloP100: 0.448
Variant links:
Genes affected
PLAU (HGNC:9052): (plasminogen activator, urokinase) This gene encodes a secreted serine protease that converts plasminogen to plasmin. The encoded preproprotein is proteolytically processed to generate A and B polypeptide chains. These chains associate via a single disulfide bond to form the catalytically inactive high molecular weight urokinase-type plasminogen activator (HMW-uPA). HMW-uPA can be further processed into the catalytically active low molecular weight urokinase-type plasminogen activator (LMW-uPA). This low molecular weight form does not bind to the urokinase-type plasminogen activator receptor. Mutations in this gene may be associated with Quebec platelet disorder and late-onset Alzheimer's disease. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016]
C10orf55 (HGNC:31008): (chromosome 10 putative open reading frame 55) Enables identical protein binding activity. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008324593).
BP6
Variant 10-73912301-G-A is Benign according to our data. Variant chr10-73912301-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 190258.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 742 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PLAUNM_002658.6 linkuse as main transcriptc.172G>A p.Gly58Arg missense_variant 4/11 ENST00000372764.4 NP_002649.2
C10orf55NR_160938.1 linkuse as main transcriptn.302-17C>T splice_polypyrimidine_tract_variant, intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PLAUENST00000372764.4 linkuse as main transcriptc.172G>A p.Gly58Arg missense_variant 4/111 NM_002658.6 ENSP00000361850 P1P00749-1
C10orf55ENST00000409178.5 linkuse as main transcriptn.302-17C>T splice_polypyrimidine_tract_variant, intron_variant, non_coding_transcript_variant 1

Frequencies

GnomAD3 genomes
AF:
0.00488
AC:
743
AN:
152152
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00118
Gnomad AMI
AF:
0.0164
Gnomad AMR
AF:
0.00275
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00452
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00850
Gnomad OTH
AF:
0.00191
GnomAD3 exomes
AF:
0.00466
AC:
1168
AN:
250726
Hom.:
2
AF XY:
0.00462
AC XY:
626
AN XY:
135612
show subpopulations
Gnomad AFR exome
AF:
0.000739
Gnomad AMR exome
AF:
0.00182
Gnomad ASJ exome
AF:
0.00238
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.00491
Gnomad NFE exome
AF:
0.00822
Gnomad OTH exome
AF:
0.00425
GnomAD4 exome
AF:
0.00656
AC:
9586
AN:
1461128
Hom.:
47
Cov.:
34
AF XY:
0.00642
AC XY:
4665
AN XY:
726938
show subpopulations
Gnomad4 AFR exome
AF:
0.000538
Gnomad4 AMR exome
AF:
0.00215
Gnomad4 ASJ exome
AF:
0.00256
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.000116
Gnomad4 FIN exome
AF:
0.00536
Gnomad4 NFE exome
AF:
0.00787
Gnomad4 OTH exome
AF:
0.00593
GnomAD4 genome
AF:
0.00487
AC:
742
AN:
152270
Hom.:
5
Cov.:
32
AF XY:
0.00414
AC XY:
308
AN XY:
74446
show subpopulations
Gnomad4 AFR
AF:
0.00118
Gnomad4 AMR
AF:
0.00275
Gnomad4 ASJ
AF:
0.00202
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00452
Gnomad4 NFE
AF:
0.00848
Gnomad4 OTH
AF:
0.00189
Alfa
AF:
0.00694
Hom.:
12
Bravo
AF:
0.00463
TwinsUK
AF:
0.00593
AC:
22
ALSPAC
AF:
0.00571
AC:
22
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.00895
AC:
77
ExAC
AF:
0.00530
AC:
643
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.00769
EpiControl
AF:
0.00729

ClinVar

Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 31, 2019- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJun 01, 2024PLAU: BP4, BS2 -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Hirschsprung disease, susceptibility to, 1 Uncertain:1
Uncertain significance, no assertion criteria providedresearchDepartment of Genetics, Reproduction and Fetal Medicine., Institute of Biomedicine of Seville (IBIS), University Hospital Virgen del Rocío/CSIC/University of Seville.Apr 01, 2015- -
Quebec platelet disorder Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.45
CADD
Benign
17
DANN
Benign
0.60
DEOGEN2
Benign
0.0020
.;T;.
Eigen
Benign
-0.70
Eigen_PC
Benign
-0.62
FATHMM_MKL
Benign
0.26
N
LIST_S2
Benign
0.72
T;T;.
M_CAP
Benign
0.031
D
MetaRNN
Benign
0.0083
T;T;T
MetaSVM
Benign
-1.0
T
MutationTaster
Benign
1.0
D;D;N;N;D;D
PrimateAI
Benign
0.29
T
PROVEAN
Benign
0.65
.;N;N
REVEL
Benign
0.050
Sift
Benign
0.50
.;T;T
Sift4G
Benign
0.72
T;T;T
Polyphen
0.18
.;B;.
Vest4
0.23, 0.23
MutPred
0.39
Loss of ubiquitination at K56 (P = 0.0457);.;Loss of ubiquitination at K56 (P = 0.0457);
MVP
0.62
MPC
0.38
ClinPred
0.0063
T
GERP RS
-0.24
gMVP
0.64

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs55744193; hg19: chr10-75672059; COSMIC: COSV65640919; COSMIC: COSV65640919; API